POWAY, Calif., Sept. 8 /PRNewswire/ — NEXUS Biosystems, Inc., a
leading innovator and worldwide provider of automated sample
management systems, today announced the completion of the
acquisition of REMP AG of Switzerland, a wholly-owned subsidiary of
the Tecan Group.
NEXUS announced on July 15, 2010 that it would acquire Tecan’s
worldwide REMP Sample Management business. REMP is a leading
global provider of sample management systems and related sample
management devices, instruments, consumables and software.
With this acquisition, NEXUS will be adding to its current
operations in the United States and Germany the REMP operations in
Switzerland, Germany, Japan and the United States. REMP
provides additional R&D, manufacturing, sales and customer
support operations in Switzerland and direct sales and customer
support in Kawasaki, Japan.
John Lillig‚ CEO of NEXUS Biosystems, commented: “Both
REMP and NEXUS have been strong innovators and leaders in the
growing global automated chemical and biological sample management
markets. Together, with our new REMP colleagues, we look
forward to continuing to provide leading sample management
solutions to our biopharmaceutical, biorepository, diagnostic,
forensic, agrochemical and genomic research customers around the
world. The combined NEXUS-REMP resources will strengthen our
overall capabilities with expanded first-class service and support
for our worldwide customers and a growing pipeline of new product
offerings for the growing global sample management community.”
About NEXUS Biosystems:
NEXUS Biosystems (www.nexusbio.com) is a leading
innovator and worldwide provider of enabling technologies and
automated sample management systems for pharmaceutical, biotech,
biorepository, agrochemical and related research institutions
worldwide. NEXUS products include the NEXUS Universal Store
family of a
‘/>”/>
